CDSCO orders action against unapproved enclomiphene drugs

Priyanka Sharma is a journalist at Mint, where she covers the Union Ministry of Health and the pharmaceutical industry. Her work focuses on explaining administration policies and how they impact healthcare and the medicine market in India. With 12 years…

HealthNews Info Wire1 min read
CDSCO orders action against unapproved enclomiphene drugs

What happened

Priyanka Sharma is a journalist at Mint, where she covers the Union Ministry of Health and the pharmaceutical industry. Her work focuses on explaining administration policies and how they impact healthcare and the medicine market in India. With 12 years of experience in journalism, she has built a reputation for providing clear and honest news on significant health topics that affect the entire country.<br><br>Her educational background includes a journalism degree from the prestigious Indian Institute of Mass Communication (IIMC) and specialized training in public health from the Public Health Foundation of India. Before her current role at Mint, Priyanka worked with India Today, The Pioneer, and ANI. She additionally served as a lead consultant for the National Health Authority. It provided her firsthand knowledge of how the administration manages large-scale health programmes.<br><br>Priyanka is based in New Delhi and is an avid traveller who loves visiting the mountains. She has a great interest in regional flavours, particularly South Indian food.

The bottom line

For now, CDSCO orders action against unapproved enclomiphene drugs remains the part of the story worth watching, and further updates are likely as more details are confirmed.

Leave a Reply

Your email address will not be published. Required fields are marked *